Holen Sie sich die Stockscreener-App
33.23
1.90%
0.62
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$32.61
Offen:
$32.63
24-Stunden-Volumen:
543.04K
Relative Volume:
0.61
Marktkapitalisierung:
$1.67B
Einnahmen:
$203.27M
Nettoeinkommen (Verlust:
$-4.66M
KGV:
-332.30
EPS:
-0.1
Netto-Cashflow:
$3.47M
1W Leistung:
-4.87%
1M Leistung:
+7.44%
6M Leistung:
+125.14%
1J Leistung:
+83.19%
1-Tages-Spanne:
$32.37
$34.19
1-Wochen-Bereich:
$30.98
$35.05
52-Wochen-Spanne:
$9.215
$36.00
Axogen Inc Stock (AXGN) Company Profile
Firmenname
Axogen Inc
Sektor
Branche
Telefon
(386) 462-6817
Adresse
13631 PROGRESS BLVD., ALACHUA, FL
Compare AXGN vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AXGN
Axogen Inc
|
33.23 | 1.64B | 203.27M | -4.66M | 3.47M | -0.10 |
|
ABT
Abbott Laboratories
|
112.68 | 193.83B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
366.05 | 140.01B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
99.49 | 129.33B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.73 | 109.92B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
75.87 | 44.36B | 6.07B | 1.06B | 799.60M | 1.8527 |
Axogen Inc Stock (AXGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-01 | Eingeleitet | Mizuho | Outperform |
| 2025-03-17 | Eingeleitet | Lake Street | Buy |
| 2024-07-01 | Eingeleitet | Raymond James | Outperform |
| 2022-11-11 | Fortgesetzt | Jefferies | Buy |
| 2022-05-09 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2022-03-11 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2020-10-23 | Eingeleitet | Guggenheim | Buy |
| 2020-06-16 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2020-05-07 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2020-04-02 | Herabstufung | BTIG Research | Buy → Neutral |
| 2019-08-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-07-12 | Eingeleitet | Canaccord Genuity | Buy |
| 2018-03-02 | Bestätigt | Lake Street | Buy |
| 2018-01-05 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2017-11-30 | Eingeleitet | Jefferies | Buy |
| 2017-11-21 | Bestätigt | Lake Street | Buy |
| 2017-07-31 | Eingeleitet | Leerink Partners | Outperform |
| 2017-06-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-03-06 | Eingeleitet | ROTH Capital | Buy |
| 2016-11-22 | Hochstufung | Lake Street | Hold → Buy |
| 2016-11-07 | Bestätigt | Wedbush | Outperform |
| 2016-11-03 | Herabstufung | Lake Street | Buy → Hold |
| 2016-08-04 | Bestätigt | Wedbush | Outperform |
| 2014-05-14 | Eingeleitet | Dawson James | Buy |
| 2013-10-31 | Bestätigt | Ladenburg Thalmann | Buy |
Alle ansehen
Axogen Inc Aktie (AXGN) Neueste Nachrichten
Lobbying Update: $15,000 of AXOGEN CORPORATION lobbying was just disclosed - Quiver Quantitative
Is Axogen Inc. stock a good pick for beginnersEarnings Overview Summary & Smart Investment Allocation Tips - mfd.ru
Liquidity Mapping Around (AXGN) Price Events - Stock Traders Daily
Will Axogen Inc. outperform tech stocksJuly 2025 Price Swings & Weekly Stock Breakout Alerts - mfd.ru
Axogen, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 - The Manila Times
Axogen, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 - GlobeNewswire Inc.
Breakeven Is Near for Axogen, Inc. (NASDAQ:AXGN) - Yahoo Finance
Aug Levels: What is the implied volatility of ORKAJuly 2025 EndofMonth & Weekly Top Stock Performers List - baoquankhu1.vn
Volatility Watch: Can Mercantile Bank Corporation stock outperform in a bear market2025 Year in Review & Verified Technical Signals - baoquankhu1.vn
Bessemer Group Inc. Purchases Shares of 810,951 AxoGen, Inc. $AXGN - MarketBeat
AxoGen, Inc. (NASDAQ:AXGN) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Brown Capital Management LLC Makes New Investment in AxoGen, Inc. $AXGN - MarketBeat
AxoGen (NASDAQ:AXGN) Sets New 1-Year HighHere's Why - MarketBeat
Y Intercept Hong Kong Ltd Lowers Holdings in AxoGen, Inc. $AXGN - MarketBeat
Axogen (AXGN) Is Up 6.2% After Expanding Financing Capacity With Universal Shelf RegistrationHas The Bull Case Changed? - simplywall.st
Why (AXGN) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Analyst Upgrade: How does Axogen Inc correlate with Nasdaq2025 Momentum Check & Weekly High Return Opportunities - baoquankhu1.vn
AxoGen, Inc. (AXGN) Stock Analysis: Exploring a 23.5% Revenue Growth and 8.82% Upside Potential - DirectorsTalk Interviews
Axogen Inc (AXGN) Trading Down 2.86% on Jan 28 - GuruFocus
Analysts Offer Insights on Healthcare Companies: AxoGen (AXGN) and Viking Therapeutics (VKTX) - The Globe and Mail
Axogen stock hits 52-week high at 34.79 USD By Investing.com - Investing.com Australia
Aug Levels: Is Axogen Inc a play on infrastructure spendingWeekly Trading Summary & Expert Approved Trade Ideas - baoquankhu1.vn
AxoGen (NASDAQ:AXGN) Sets New 52-Week High Following Analyst Upgrade - MarketBeat
Axogen Inc (AXGN) Trading 4.65% Higher on Jan 26 - GuruFocus
Axogen stock hits 52-week high at 34.79 USD - Investing.com
Income Plays: Is DESP on track to beat earningsRate Hike & Weekly High Conviction Trade Ideas - baoquankhu1.vn
Axogen, Inc. (NASDAQ:AXGN) On The Verge Of Breaking Even - 富途牛牛
A Look At Axogen (AXGN) Valuation After Its Upsized US$124 Million Equity Offering - Yahoo Finance
Axogen Upsized Equity Raise Shifts Debt Profile And Valuation Focus - Sahm
Is Axogen Inc.’s growth already priced inJuly 2025 Technicals & Fast Entry and Exit Trade Plans - mfd.ru
AxoGen (NASDAQ:AXGN) Rating Increased to Strong-Buy at Wall Street Zen - MarketBeat
Axogen (AXGN) Is Up 5.8% After Upsized Equity Raise and Debt PaydownWhat's Changed - Yahoo Finance
AxoGen Announces Equity Offering to Repay Term Loan - The Globe and Mail
Axogen Signs Underwriting Agreement With Wells Fargo Securities and Mizuho Securities USA - TradingView
Axogen (AXGN) prices stock offering and targets $69.7M term loan payoff - Stock Titan
Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (RANI), Ardelyx (ARDX) and AxoGen (AXGN) - The Globe and Mail
AxoGen (NASDAQ:AXGN) Shares Gap DownTime to Sell? - MarketBeat
Axogen Shares Drop After Pricing $124 Million Stock Offering - marketscreener.com
Axogen plans $85 million stock offering to repay debt By Investing.com - Investing.com Australia
Axogen stock dips after pricing $124M offering - MSN
Axogen (AXGN) Increases Stock Offering to $124 Million - GuruFocus
Axogen (AXGN) Shares Decline After Upsized Public Offering - GuruFocus
Axogen prices upsized public offering of common stock at $31 per share - Investing.com Nigeria
Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock - The Manila Times
Surgical nerve repair company Axogen prices $124M stock sale to pay off term loan - Stock Titan
Axogen Announces Pricing Of Upsized $124 Million Public Offering Of Common Stock - TradingView
Axogen announces proposed $85M public stock offering; shares down - MSN
AXGN stock rises pre-market after FDA approves nerve repair graft - MSN
Axogen stock falls after $85 million share offering announcement By Investing.com - Investing.com Nigeria
Finanzdaten der Axogen Inc-Aktie (AXGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.33%
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):